CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 14 enrolled
Drug / intervention
Relaxation Response Resiliency Program for Father of CYSHCNbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05535348
NCT05535348N/ACompleted
CompareCT.gov

Evaluation of a Resiliency Program for Fathers of Children and Youth With Special Health Care Needs

Massachusetts General Hospital·interventional·Posted Sep 10, 2022·Updated Jul 3, 2023

In Brief

A clinical study evaluating Relaxation Response Resiliency Program for Father of CYSHCN for Stress and 2 related conditions. Completed, enrolled 14 participants across 1 site.

Detailed Summary

Based on findings from our prior trials with parents of children with learning and attentional disabilities and parents of children with autism spectrum disorder (Kuhlthau et al., 2020; Park et al., 2020; IRB approved: #:2016P001622 and 2016P002037 respectively), the investigators propose to pilot test and refine the adapted resiliency intervention (SMART-3RP) among fathers of children with special health care needs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStress, Family, Fathers
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedSep 10, 2022
Enrollment StartMay 6, 2022
Primary CompletionSep 29, 2022
Study CompletionOct 20, 2022
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 3.8 years ago

Interventions

Relaxation Response Resiliency Program for Father of CYSHCNbehavioral

Virtually delivered psycho-educational resiliency training program for fathers of CYSHCN